Literature DB >> 3625196

Partial protection against hyperbaric oxygen induced convulsions by dopaminergic agents in mice: possible involvement of autoreceptors?

C O Criborn, C Henriksson, S Ahlenius, V Hillegaart.   

Abstract

In the present report we have investigated the effects of apomorphine, (-)3-PPP, L-DOPA and haloperidol on the elicitation of convulsions induced in mice by exposure to oxygen at high pressure (HBO) (5 ata O2). It was found that the administration of apomorphine (0.025-0.1 mg X kg-1 s.c.), (-)3-PPP (4 mg X kg-1 i.p.) L-DOPA (200-400 mg X kg-1 i.p.) as well as haloperidol (0.25-2.0 mg X kg-1 i.p.) produced a significant protection against HBO-induced convulsions. Haloperidol was the only drug to produce a dose-dependent decrease in respiration, and this effect does probably explain the anticonvulsant effects observed. The low doses at which apomorphine was effective, and the effects produced by (-)3-PPP, indicate an effect mediated via DA autoreceptors. Alternatively, and more likely taking the effects of L-DOPA into account, the DA receptors involved are sensitive enough to disclose postsynaptic agonist properties of apomorphine and (-)3-PPP at the doses employed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625196     DOI: 10.1007/BF01244348

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  12 in total

Review 1.  The role of the neurotransmitters in the epilepsies.

Authors:  E W Maynert; T J Marczynski; R A Browning
Journal:  Adv Neurol       Date:  1975

2.  Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice.

Authors:  W H Riffee; M C Gerald
Journal:  Neuropharmacology       Date:  1976-11       Impact factor: 5.250

3.  The antagonism between reserpine and some antiparkinson drugs in electroseizure.

Authors:  I Jurna; B Regélhy
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

5.  Recording of the respiratory process in mice without strain on the respiratory organs.

Authors:  C O Criborn
Journal:  Life Sci       Date:  1969-12-01       Impact factor: 5.037

6.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

7.  Letter: Effects of dopamine receptor stimulation and blockade on Ro 4-1284-induced enhancement of electroshock seizure.

Authors:  R E Stull; P C Jobe; P F Geiger; G G Ferguson
Journal:  J Pharm Pharmacol       Date:  1973-10       Impact factor: 3.765

8.  Blockade of biogenic amine synthesis: its effect on the responses to leptazol and dexamphetamine in rats.

Authors:  P S Spencer; T A Turner
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

9.  Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

Authors:  S Hjorth; A Carlsson; D Clark; K Svensson; H Wikström; D Sanchez; P Lindberg; U Hacksell; L E Arvidsson; A Johansson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Amphetamine as a protective agent against oxygen-induced convulsions in mice.

Authors:  C O Criborn; C J Clemedson; C Henriksson
Journal:  Aviat Space Environ Med       Date:  1986-08
View more
  1 in total

1.  Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.

Authors:  S Ahlenius; V Hillegaart; A Wijkström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.